Inadequate DI governance during data review – remediation roadmap regulators expect


Published on 29/01/2026

Addressing Gaps in Data Integrity Governance During Review Processes

Failings in data integrity governance during the review phase can lead to significant compliance risks for pharmaceutical organizations. When data inconsistencies arise, they can result not only in operational disturbances but also in reputational damage and regulatory scrutiny. This article provides a comprehensive playbook designed to equip quality assurance (QA), production, engineering, and regulatory affairs (RA) professionals with actionable insights to identify, contain, and remediate data integrity (DI) issues effectively.

If you want a complete overview with practical prevention steps, see this Data Integrity Compliance.

After studying this playbook, you will be able to recognize signals on the production floor or laboratory indicating inadequate DI governance, implement rapid containment strategies, conduct thorough investigations, and maintain inspection-readiness with a robust documentation framework.

Symptoms/Signals on the Floor or in the Lab

Recognizing symptoms of inadequate DI governance is critical in minimizing compliance risks. Common signals include:

  • Inconsistent Data Records: Variations
in data entries or discrepancies between source and reported data may indicate poor governance systems.
  • Incorrect or Missing Metadata: Gaps in metadata (time stamps, author identities, etc.) may suggest potential violations of data integrity principles.
  • Frequent User Access Violations: Anomalies in user access patterns can suggest unauthorized data manipulation or inadequate controls.
  • Audit Trail Failures: Failure to maintain comprehensive records of changes can signal weak governance.
  • Regulatory Findings: Any adverse findings during audits from entities like the FDA or EMA highlight governance concerns.
  • Increased Error Rates: An uptick in errors in batch production records can be a direct consequence of governance failures.
  • Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

    Understanding the underlying causes of governance failures can direct effective remediation efforts. Here’s a breakdown of likely causes segmented by category:

    Category Likely Causes
    Materials Use of non-compliant data sources, lack of control over third-party data inputs.
    Method Insufficiently defined procedures for data entry and review.
    Machine Outdated or non-compliant data management systems.
    Man Lack of training on data integrity principles and compliance expectations.
    Measurement Faulty measurement tools leading to incorrect data capture.
    Environment Inadequate IT infrastructure or controls leading to data security issues.

    Immediate Containment Actions (first 60 minutes)

    When an issue is identified, prompt action is necessary. Here are immediate steps to take within the first hour:

    1. Identify Affected Data: Quickly locate and isolate affected data sets, noting dates, authors, and version histories.
    2. Notify Stakeholders: Inform QA, production, and relevant department heads about the potential issue.
    3. Initiate Access Controls: Temporarily restrict access to the affected systems to prevent further manipulation.
    4. Document Initial Findings: Capture key observations and triggers for the incident to maintain a clear record for the investigation.
    5. Control Communication: Maintain communication with all stakeholders but limit detailed sharing of information until the investigation is underway.

    Investigation Workflow (data to collect + how to interpret)

    An effective investigation requires a systematic approach to data collection and interpretation. Follow these steps:

    • Data Collection: Gather logs from systems, including access logs, audit trails, and any relevant source data. Look for correlations between user actions and data modifications.
    • Interviews: Speak with personnel involved in data entry or review processes to gather insights about their actions and any challenges faced.
    • Cross-Verification: Compare recorded data with confirmed original sources to identify discrepancies.
    • Pattern Analysis: Analyze patterns in the data over time to identify consistent issues, using statistical methods if applicable.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    Employing root cause analysis tools is vital to uncover the underlying issues behind governance failures:

    1. 5-Why Analysis: Useful in simple scenarios to drill down into the root cause by repeatedly asking “why” the problem occurred.
    2. Fishbone Diagram: Ideal for more complex situations where multiple contributing factors exist. It categorizes potential causes into relevant groups.
    3. Fault Tree Analysis: Best used in systematic reviews where you plot logical pathways leading to failures, useful for software systems.

    CAPA Strategy (correction, corrective action, preventive action)

    A robust Corrective and Preventive Action (CAPA) strategy must be established once root causes are identified:

    • Correction: Immediate correction of data inaccuracies, ensuring all data is corrected in compliance with relevant standards.
    • Corrective Action: Implement solutions addressing the root causes, such as enhancing data entry training or upgrading software systems.
    • Preventive Action: Develop strategies to mitigate recurrence risks, including regular audits and updates to governance procedures.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    Establishing a control strategy ensures proactive detection of data integrity issues:

    • Statistical Process Control (SPC): Use SPC tools to monitor data entry trends over time, spotting deviations from normal patterns.
    • Sampling Procedures: Regularly sample data entries for thorough review to identify potential patterns of non-compliance.
    • Alarm Systems: Implement alert mechanisms for outlier detection in data logs, ensuring timely intervention when anomalies are detected.
    • Testing Verification: Regular verification exercises of data entries against known sources to ensure continuous compliance.

    Validation / Re-qualification / Change Control impact (when needed)

    When data integrity governance is compromised, subsequent validation and change control processes are critical:

    Related Reads

    • Validation: Re-evaluate impacted systems for compliance with regulations, ensuring that all data management processes are revalidated accordingly.
    • Re-qualification: Retain records of re-qualification activities to show comprehensive impact assessment in case of a regulatory audit.
    • Change Control: Implement controls regarding affected systems or processes, ensuring they align with revised governance protocols.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    Maintaining inspection readiness involves comprehensive documentation that supports compliance efforts:

    • Change Logs: Document changes and updates made to data governance procedures, ensuring they’re accessible for review.
    • Audit Trail Documentation: Ensure that audit trails are intact and demonstrate unedited records of any changes made to data.
    • Batch Documentation: Maintain thorough records of batch production activities with confirmations that the recorded data meets governance standards.
    • Deviation Reports: Keep detailed reports of any deviations observed during data review processes to facilitate future audits.

    FAQs

    What is data integrity governance?

    Data integrity governance refers to the frameworks and practices that ensure accuracy, reliability, and compliance of data within pharmaceutical operations.

    How does inadequate data integrity governance affect regulatory submissions?

    Staffing audits and investigations due to governance failings can lead to delayed submissions, penalties, and increased scrutiny from authorities like the FDA and EMA.

    What are ALCOA+ principles?

    ALCOA+ stands for Attributable, Legible, Contemporaneous, Original, and Accurate, and it governs the standards for data integrity in regulated environments.

    How can I improve data integrity governance in my organization?

    Conduct training sessions, update governance policies, implement robust software systems, and regularly audit data to foster a culture of integrity.

    What are the steps in a CAPA process?

    The CAPA process includes identifying the issue, investigating the root causes, implementing corrective and preventive actions, and verifying the effectiveness of those actions.

    How often should data be audited for compliance?

    Data audits should be conducted regularly depending on the organization’s risk assessment, but at a minimum, audits should be annual.

    What tools can help in monitoring data integrity?

    Statistical Process Control (SPC), audit trail software, and data management systems can assist in maintaining oversight of data integrity.

    Are there specific regulations for data integrity?

    Yes, regulations are outlined by entities such as the FDA, EMA, and ICH providing frameworks that govern data integrity standards in pharmaceutical contexts.

    How do I prepare for a regulatory inspection?

    Ensure all documentation is complete, organize all relevant records, and conduct mock inspections to identify areas needing attention.

    What impact does serialization have on data integrity?

    Serialization requires accurate data management practices to ensure compliance with tracking and traceability regulations aimed at preventing counterfeit products.

    Pharma Tip:  Unsecured raw data storage during FDA inspection – 483 risk assessment